Nagpur: Baby dies after getting MR vaccine

Published On 2018-12-22 03:45 GMT   |   Update On 2018-12-22 03:45 GMT

Nagpur: A one-year-old girl died after being administered with measles and rubella (MR) vaccination at the Government Medical College and Hospital (GMCH) here Astha Godange was vaccinated at Tumsar tehsil’s Garra village on December 15, along with her four-year-old brother Sargam.


As her condition deteriorated, she was rushed to the general hospital at Bhandara, which further referred her to GMCH in Nagpur on December 16, where she succumbed on December 17 (Tuesday), sources said and informed that her death was due to complications developed post-MR vaccination (revealed a diagnosis of gastroenteritis).

Meanwhile, her brother who was also admitted to the hospital was given discharge on Wednesday.

Similarly, on December 7, an 11-year old girl, Aradhya Waghaye, the resident of Lakhni tehsil of Bhandara, died following complications developed post-MR vaccination, sources added.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News